Targinta AB
Developing targeted antibodies and ADCs for aggressive cancers.
Oversigt
- 0
- Medarbejdere
- ≤1t SEK
- Omsætning
- 2018
- Grundlagt
Nøglebeslutningstagere
Evy Lundgren-Åkerlund
CEO
Beskrivelse
Targinta AB is a Swedish biotechnology company focused on developing novel treatments for aggressive and life-threatening cancers. The company specializes in creating targeted, toxin-armed antibodies, known as Antibody-Drug Conjugates (ADCs), and functional blocking antibodies. Their entire product...
Tags
Nøgleord
Teknologistak
Virksomhedsoplysninger
- Branche
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE559157669801
Beslutningstagere
1 kontakter i FunnelfeedrEvy Lundgren-Åkerlund
CEO
Lignende virksomheder
20 lignende virksomheder i Funnelfeedr
Xintela AB
10–19 medarbejdereDeveloping stem cell and targeted cancer therapies for unmet needs.
Ascelia Pharma AB
Biotech developing novel orphan oncology drugs for unmet needs.
BioInvent International Aktiebolag
100–199 medarbejdereClinical-stage company developing novel immuno-oncology antibody therapeutics for cancer.
Ascelia Incentive AB
0 medarbejdereBiotech developing novel orphan oncology drugs for unmet medical needs.
Affibody Medical AB
Developing next-generation radiopharmaceuticals using proprietary Affibody platform.
Udforsk mere
Spørgsmål om Targinta AB
Vil du se Funnelfeedr i aktion?
Book en gratis demo og opdag, hvordan Funnelfeedr hjælper dig med at finde og konvertere dine ideelle kunder.
Book en demo